Evidence map›Paper›PMID 34704738›Full record

ArticleAnalytical chemistry2021

Extending the Scope of

G A Nagana Gowda, Vadim Pascua, Daniel Raftery

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Multiplatform untargeted metabolomics.Magnetic resonance in chemistry : MRC · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. A new limit for blood metabolite analysis usingJournal of magnetic resonance open · 2022
    Article
  13. Review
  14. Article
  15. NMR-based metabolomics: Where are we now and where are we going?Progress in nuclear magnetic resonance spectroscopy
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Vadim Pascua
Daniel RafteryFred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States.ORCID 0000-0003-2467-8118
University of Washington · USFred Hutch Cancer Center · US

Funding

PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
UW Center for Translational Muscle Research (Overall Application)P30AR074990 · NIAMS · UNIVERSITY OF WASHINGTON · PI Jennifer Michelle Davis, DANIEL RAFTERY · 2019 to 2026
$7.5M
Quantitative Analysis of Labile Metabolites in Biological SamplesR01GM138465 · NIGMS · UNIVERSITY OF WASHINGTON · PI GOWDA, G. A. NAGANA, RAFTERY, DANIEL · 2021 to 2024
$1.5M
NIAMS NIH HHS P30 AR074990NIDDK NIH HHS P30 DK035816NIGMS NIH HHS R01 GM138465
6 · The paper itself

Abstract

Glutathione is a ubiquitous cellular antioxidant, which is critically required to protect cells from oxidative damage and free radical injury. It is practically impossible to analyze glutathione in its native form after isolation from biological mixtures since the active form (reduced glutathione, GSH) spontaneously gets converted to the oxidized form (oxidized glutathione, GSSG). To address this challenge, numerous highly sensitive detection methods, including mass spectrometry, have been used in conjunction with derivatization to block the oxidation of GSH. Efforts so far to quantitate GSH and GSSG using the nuclear magnetic resonance (NMR) spectroscopy method have remained unsuccessful. With a focus on addressing this challenge, in this study, we describe an extension to our recent whole blood analysis method [

Indexed as

AntioxidantsGlutathioneAdenosine TriphosphateGlutathione DisulfideHumansMetabolomicsOxidation-ReductionProton Magnetic Resonance SpectroscopyAdenosine TriphosphateAntioxidantsGlutathioneGlutathione Disulfide

Identifiers

PMID34704738
PMCPMC8822164
OpenAlexW3211109985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.